|
| | Avatrombopag maleate Basic information |
| Product Name: | Avatrombopag maleate | | Synonyms: | 677007-74-8 (MALEATE) 570406-98-3 (FREE BASE);Avatrombopag Meleate;1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid;Avatrombopag Maleate;Avatrombopag maleate，677007-74-8(MALEATE)570406-98-3(FREEBASE);Avatrombopag MaleateQ: What is
Avatrombopag Maleate Q: What is the CAS Number of
Avatrombopag Maleate;4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thi azolyl]amino]carbonyl]-2-pyridinyl]-, (2Z)-2-butenedioate (1:1);Avatrombopag Dimaleate | | CAS: | 677007-74-8 | | MF: | C33H38Cl2N6O7S2 | | MW: | 765.72 | | EINECS: | | | Product Categories: | chemical;API;677007-74-8 | | Mol File: | 677007-74-8.mol |  |
| | Avatrombopag maleate Chemical Properties |
| | Avatrombopag maleate Usage And Synthesis |
| Description | Avatrombopag maleate is a thrombopoietin receptor (TPO) agonist developed by AkaRx Inc and approved by the US FDA in May 2018 as Doptelet (20mg). For the treatment of low platelet count (thrombocytopenia CIT) in adult patients with chronic liver disease (CLD) who are scheduled to undergo medical or dental surgery.
| | Uses | Avatrombopag Maleate is the maleate salt form of avatrombopag, an orally available platelet thrombopoietin receptor (TPOR; MPL) agonist, with potential megakaryopoiesis stimulating activity. | | Mechanism of action | Upon administration, Avatrombopag maleate binds to and stimulates TPOR, which may lead to the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells. This increases the production of platelets and may prevent chemotherapy-induced thrombocytopenia (CIT). TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily. | | Synthesis | The synthesis of Avatrombopag maleate is as follows:
A mixture containing 80.1 g of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexyl piperazin-1-yl) thiazol-2-yl] carbamoyl} pyridin-2-yl) piperidine-4-carboxylic acid, 580 mL of DMSO, 580 mL of acetone, 17.2 g of maleic acid, and 290 mL of water was stirred at 69 °C. The insoluble matter was filtered out, washed with a mixture of 32 mL of DMSO, 32 mL of acetone, and 16 mL of water, and then the filtrate was cooled and the precipitate was collected by filtering. Washing was successively performed using 150 mL of water, 80 mL of acetone, 650 mL of water, and 80 mL of acetone, followed by drying, to obtain 70.66 g of Avatrombopag maleate.
 |
| | Avatrombopag maleate Preparation Products And Raw materials |
|
